Evidence map›Paper›PMID 21374098›Full record

ArticleDer Orthopade2011

[Patient pathways in thrombosis prophylaxis after hip and knee replacement surgery : results of a survey].

S Müller, T Wilke, M Pfannkuche, I Meber, A Kurth, H Merk, F Steinfeldt, D Ganzer, C Perka

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Der Orthopade, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

S MüllerInstitut für Pharmakoökonomie und Arzneimittellogistik (IPAM), Hochschule Wismar, PF 1210, 23952, Wismar, Deutschland.
T Wilke
M Pfannkuche
I Meber
A Kurth
H Merk
F Steinfeldt
D Ganzer
C Perka
Wismar University of Applied Sciences · DEAsklepios Kliniken Bad Abbach · DEBoehringer Ingelheim (Germany) · DECharité - Universitätsmedizin Berlin · DEDietrich Bonhoeffer Klinikum · DEKlinik und Poliklinik für Psychosomatische Medizin und Psychotherapie · DEUniversitätsmedizin Greifswald · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A key element of patient care after hip and knee replacement is medication-based thrombosis prophylaxis. Due to decreasing lengths of acute hospital stays the question arises to what extent outpatients are taking responsibility thrombosis prophylaxis (patient pathway analysis).To analyze patient pathways a telephone survey of 668 patients was conducted. On average patients were interviewed 38 days following surgery with a focus on low molecular weight heparins. The analysis showed that nearly 90% of patients need to carry out thrombosis prophylaxis in an outpatient or home environment for at least 1 day and for 47.2% of patients a linking period between acute and rehabilitation stay is relevant. The obviously existing quantitative importance of outpatient thrombosis prophylaxis is also reflected by its duration and 45.7% of interviewed patients needed at least 5 days of outpatient prophylaxis.Outpatient thrombosis prophylaxis clearly makes high demands on the patients, in particular when combined with the task of administering complex forms of injections. Those involved in inpatient and outpatient provision of care should not assume that all patients carry out the necessary prophylaxis at the required level of reliability. On the contrary initial evidence shows that the non-adherence of patients during ambulatory thrombosis prophylaxis presents a genuine challenge to care providers.

Indexed as

Arthroplasty, Replacement, HipArthroplasty, Replacement, KneeMedication AdherenceAgedAmbulatory CareAnticoagulantsDrug Therapy, CombinationFemaleGermanyHealth SurveysHeparin, Low-Molecular-WeightHumansInjections, SubcutaneousLength of StayMaleMiddle AgedAnticoagulantsHeparin, Low-Molecular-Weight

Identifiers

PMID21374098
OpenAlexW7362478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.